ArticleMolecular therapy oncolytics2021

Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment.

Joseph W Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.